Recent news on Dexrazoxane

TopoTarget of Denmark buys Swiss biotech firm Apoxis for 14.5 ...  -  Apr 12, 2007
Pharma Times (subscription),He added that following the recent launch of the firm's first product, Savene (dexrazoxane) for the treatment of anthracycline extravasation,

European Society for Medical Oncology - Press Program for the 31st ...  Sep 21, 2006
Treatment Effectively Treats Feared Complication Of Chemotherapy Two multicenter studies have shown that the drug dexrazoxane can effectively treat accidental ... -PR Newswire

High-dose Dense Chemotherapy and Radiation Therapy for Women with ...  Jul 21, 2006
Feasibility of radiotherapy after high-dose dense chemotherapy with epirubicin, preceded by dexrazoxane, and paclitaxel for patients with high-risk stage II ... -Cancer Consultants

Study Indicates Heart Damage From Some Cancer Drugs Worsens Over ...  Jul 19, 2006
Furthermore, there were cardioprotective drugs, such as dexrazoxane available now, which were not available to earlier patients. ... -Medical News Today



Cardioxane® (Dexrazoxane) Reduces Anthracycline-Induced Cardiac ...  May 10, 2006
Researchers involved in a multicenter European trial have reported that Cardioxane significantly reduces the incidence and severity of anthracycline-induced ... - Cancer Consultants

Dexrazoxane Reduces Side Effects to the Heart During Subsequent ...  Apr 21, 2006
According to an article recently published in the Annals of Oncology, the agent dexrazoxane (Cardioxane®) protects the heart from damage of continued ... - Cancer Consultants

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional